Detalles de la búsqueda
1.
Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
J Clin Oncol
; 23(21): 4719-25, 2005 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16034047
2.
Influence of food intake and formulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist.
J Clin Pharmacol
; 42(3): 283-9, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11865964
3.
Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients.
Cancer Chemother Pharmacol
; 49(3): 225-34, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11935215
4.
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer.
Cancer Chemother Pharmacol
; 52(3): 193-201, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12783206
5.
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers.
Antimicrob Agents Chemother
; 50(1): 279-85, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16377698
6.
Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers.
Antimicrob Agents Chemother
; 50(1): 286-93, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16377699
7.
Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.
Antimicrob Agents Chemother
; 48(7): 2570-5, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15215110
8.
Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.
Antimicrob Agents Chemother
; 48(7): 2576-80, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15215111
Resultados
1 -
8
de 8
1
Próxima >
>>